Platelet count predicts prognosis in operable non-small cell lung cancer
Open Access
- 12 March 2013
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 5 (5), 1351-1354
- https://doi.org/10.3892/etm.2013.1003
Abstract
Platelets play a significant role in cancer cell growth, progression and metastasis. However, in non‑small cell lung cancer (NSCLC), the association between a patient's platelet count and prognosis has not previously been fully elucidated. The aim of the present study was to investigate the correlation between platelet count, patients' characteristics and prognosis in patients with NSCLC. A total of 510 NSCLC patients were enrolled in the present study. The median platelet count in the NSCLC patients was 203x109/l (95% CI, 115‑358x109/l). The median platelet count in T3 and T4 patients was significantly higher than that of T1 and T2 patients (median, 263x109/l and 253.5x109/l vs. 199.5x109/l and 196.5x109/l, respectively; P<0.001). The 3‑year cumulative overall survival (OS) probability was 75.3% for patients with normal platelet counts and 59.2% for patients with elevated platelet counts. When compared with the patients with normal platelet counts, the patients with elevated platelet counts had an increased risk of disease progression (HR, 1.568; 95% CI, 1.015‑2.453). Pre‑operative platelet counts are a novel independent prognostic biomarker in operable NSCLC.Keywords
This publication has 23 references indexed in Scilit:
- Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancerEuropean Journal of Surgical Oncology, 2012
- Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX studyThe Lancet Oncology, 2011
- Modulation of Natural Killer Cell Anti-Tumor Reactivity by PlateletsJournal of Innate Immunity, 2011
- The Acellular Fraction of Stored Platelets Promotes Tumor Cell InvasionJournal of Surgical Research, 2009
- Prognostic impact of thrombocytosis in resectable non-small cell lung cancerInteractive CardioVascular and Thoracic Surgery, 2008
- Thrombocytosis associated with poor prognosis in patients with esophageal carcinomaJournal of the American College of Surgeons, 2004
- Thrombocytosis as a Useful Prognostic Indicator in Patients with Lung CancerRespiration, 2004
- Evidence that platelets promote tube formation by endothelial cells on matrigelBritish Journal of Pharmacology, 1998
- Prognostic significance of thrombocytosis in patients with primary lung cancerEuropean Respiratory Journal, 1996
- Blood Analyses as Prognostic Factors in Primary Lung CancerActa Oncologica, 1990